Clinical Trial Update: A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption [Phase 2]

View source ↗

Summary

Phase 2 study evaluating topical steroids as preemptive therapy for EGFR inhibitor–induced papulopustular eruption; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acneiform Rash
• Papulopustular Eruption

Snippet

Sponsor: Northwestern University | Conditions: Acneiform Rash, Papulopustular Eruption | Phase 2 | Status: TERMINATED | Results posted: 2023-05-17